Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Oncolytics Biotech Inc. (ONCY) had Income from Continuous Operations of $-23.14M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-23.14M |
|
-- |
|
-- |
|
$25.53M |
|
$-25.53M |
|
$2.48M |
|
$-23.05M |
|
$-23.05M |
|
$-23.14M |
|
|
Income from Continuous Operations |
$-23.14M |
$-23.14M |
|
$-23.14M |
|
$-25.53M |
|
$-25.22M |
|
76.48M |
|
76.48M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$13.78M |
|
$0.30M |
|
$0.96M |
|
$14.73M |
|
$4.88M |
|
-- |
|
$5.49M |
|
$10.37M |
|
$4.37M |
|
$4.37M |
|
$4.37M |
|
80.02M |
|
| Cash Flow Statement Financials | |
$-19.68M |
|
$-0.17M |
|
$4.84M |
|
$25.48M |
|
$11.63M |
|
$-13.84M |
|
$1.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-530.00% |
|
-530.00% |
|
-157.08% |
|
-530.00% |
|
$0.05 |
|
$-0.26 |
|
$-0.26 |
|